No. HT942526BMFRPRDA · Defense Health Agency Contracting Activity - DHACA
DoW Bone Marrow Failure, Resource Development Award
- Award range
- Not specified
- Expected awards
- ~1
- Application deadline
- Nov 4, 2026
- Posted
- Jun 17, 2026
- Last verified
- 3 days ago
At a glance
AI summaryThe FY26 Bone Marrow Failure Research Program Resource Development Award funds development of a multiomic atlas from well-annotated human bone marrow failure samples, with an open-access data resource for researchers, clinicians, and the public. Eligible applicants include U.S. Department of War organizations and domestic or foreign, for-profit or nonprofit, public or private entities, and principal investigators at all career levels may apply if affiliated with an eligible organization. The program expects to fund about one award, with total costs capped at $1.25 million and a maximum project period of 2 years. Cost sharing is not required. The award is for bone marrow failure research only, does not allow clinical trials or animal study costs, and focuses on durable resources for the bone marrow failure research community.
AI-generated summary — verify against the announcement
What it funds
Official description from grants.gov
Summary: The fiscal year 2026 (FY26) Bone Marrow Failure Research Program (BMFRP) Resource Development Award (RDA) supports the development of a multiomic atlas generated from well-annotated human bone marrow failure (BMF) samples, with omic data derived from marrow specimens. The resulting dataset should serve as an open-access, durable resource for the BMF research and clinical communities and is expected to facilitate key discoveries that advance the understanding of BMF diseases. Distinctive Features: The application must include a robust Data Resource Sharing Plan that describes the means and timeline by which the fully developed resource will be made available to the scientific and clinical community.
Who can apply
- Unrestricted
Program history
USASpending.govAssistance listing 12.420 · Military Medical Research and Development
Real awards this federal program has made — the whole assistance listing (12.420), not just this notice.
| Fiscal year | Awards | Median award | Middle half |
|---|---|---|---|
| FY 2026 (so far) | 374 | $934,195 | $559,998 – $1,477,811 |
| FY 2025 | 967 | $796,174 | $416,995 – $1,480,602 |
| FY 2024 | 1,097 | — | — |
| FY 2023 | 1,115 | — | — |
| FY 2022 | 1,186 | — | — |
| FY 2021 | 1,023 | — | — |
Dollar figures are based on the 1,000 most recent awards we store, not all 5,762 — award counts are complete.
- THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER $19,100,256 · FY 2025
- H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. $18,696,738 · FY 2025
- UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE $10,606,583 · FY 2025
- SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH $10,500,000 · FY 2026
- UNIVERSITY OF VERMONT & STATE AGRICULTURAL COLLEGE $8,491,997 · FY 2025
Source: USASpending.gov · refreshed Aug 25, 2026